Quarterly Earnings Results Presentation Q4 2025 (February 2026) Forward Looking Statements This presentation contains certain forward-looking statements, including, but not limited to, certain plans, expectations, goals, projections, and statements, which are not historical facts and are subject to numerous assumptions, risks, and uncertainties. Statements that do not describe historical or current facts, including statements about beliefs and expectations, are forward-looking statements. All forward-lookin ...

© 2026 Fluor. YEAR END 2025 RESULTS FEBRUARY 17, 2026 © 2025 Fluor. SUNOCO MARINER EAST LNG // PENNSYLVANIA, U.S.A. 1 SAFE HARBOR STATEMENT This presentation contains forward-looking statements (including without limitation statements to the effect that the Company or its management "will," "believes," "expects," "plans," "intends," "continue," "anticipates," is "positioned" or other similar expressions). These forward-looking statements, including statements relating to resolution of outstanding claims or ...

GUIDANCE PRESENTATION 2026 2026 OUTLOOK: CONTINUED OPERATIONS | $ IN MILLIONS | | | | --- | --- | --- | | | LOW | HIGH | | RETAIL NOI | $68.5M | $70.0M | | OFFICE NOI | $58.5M | $60.0M | | EQUITY METHOD INVESTMENT ("EMI") PROPERTY INCOME(1) | $3.4M | $3.9M | | ACQUISITION NOI | $1.0M | $1.7M | | TOTAL COMMERCIAL NOI | $131.4M | $135.6M | | G&A EXPENSES | -$19.7M | -$18.7M | | INTEREST EXPENSE | -$57.2M | -$54.2M | | OTHER NOI(2) | $8.9M | $9.9M | | PREFERRED STOCK DIVIDENDS | -$11.5M | -$11.5M | | PRO FORMA ...

4Q'25 Earnings Presentation February 17, 2026 INTRODUCTIONS F O R W A R D - L O O K I N G S T A T E M E N T S This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that reflect our current views with respect to, among other things, statements regarding Waystar's expectations relating to future operating results and financial position, including full year 2026, and future periods; anticipated future investments; our industry, busine ...

4Q and Full Year 2025 Earnings Conference Call Orion S.A. Forward -Looking Statements This presentation contains and refersto certain forward-looking statements with respect to our financial condition, results of operations and business. These statements constitute forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements are statements of future expectations that are based on management's current expectat ...

Shareholder Update Fourth Quarter & Full Year 2025 February 17, 2026 eToro Group Ltd. Disclaimers This Presentation Relates to eToro's Broader Earnings Announcement Disclosures This presentation includes key performance indicators that eToro's management uses to help evaluate the business, measure its performance, identify trends, prepare financial projections and make business decisions. eToro's key performance indicators include Funded Accounts, Assets Under Administration and Net Contribution. Definition ...

FOURTH QUARTER AND FULL YEAR 2025 EARNINGS 2025 was a landmark year for Ceva and ended on a high note with record fourth-quarter revenue^ and our strongest royalty quarter in more than four years. Amir Panush, CEO 2 0 2 5 T O T A L R E V E N U E 2 0 2 5 E A R N I N G S ( L O S S ) P E R S H A R E A N N U A L R E V E N U E $109.6M +2% Year over Year ($0.44) GAAP versus ($0.37) in 2024 $0.42 NON-GAAP versus $0.36 in 2024 Q 4 ' 2 5 T O T A L R E V E N U E $31.3M Q 4 ' 2 5 E A R N I N G S ( L O S S ) P E R S H ...

Fourth Quarter and Full Year 2025 Financial and Operating Results February 17, 2026 © Copyright 2026 Krystal Biotech, Inc. All rights reserved. Forward Looking Statements and Disclosures This presentation and our discussion contain forward-looking statements that involve substantial risks and uncertainties. Any statements about future expectations, plans, and prospects for Krystal Biotech, Inc. (together with its subsidiaries, the "Company"), including but not limited to, statements about our U.S., Germany, ...

FQ3 2025-2026 Earnings Call February 17, 2026 Disclaimer Forward-Looking Information / Statements Certain statements contained in this presentation are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "plans," "expects," "believes," "anticipates," and similar words are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements concerning our e ...

February 2026 Bitopertin Regulatory Update Disclaimer and FLS This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, express or implied statements regarding Disc's expectations with respect to its preclinical studies, clinical trials and research and development programs, in particular with respect to bitopertin, DISC-0974 and DISC-3405, and any developments or results in connection therewith; project ...